{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:28:04Z","timestamp":1770067684847,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.urolonc.2023.03.006","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:38:43Z","timestamp":1684543123000},"page":"323.e1-323.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time"],"prefix":"10.1016","volume":"41","author":[{"given":"Francesco A.","family":"Mistretta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Luzzago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Piccinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Marvaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo Lo","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Nizzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Prof","given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Prof","given":"Barbara A.","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Prof","given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Prof","given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Prof","given":"Gennaro","family":"Musi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2023.03.006_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.03.006_bib0002","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.eururo.2016.06.007","article-title":"A decade of active surveillance in the PRIAS Study: An update and evaluation of the criteria used to recommend a switch to active treatment","volume":"70","author":"Bokhorst","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.03.006_bib0003","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.03.006_bib0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2017.03.009","article-title":"Low-risk prostate cancer: Identification, management, and outcomes","volume":"72","author":"Moschini","year":"2017","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2023.03.006_bib0005","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1200\/JCO.2010.32.8112","article-title":"Active surveillance program for prostate cancer: An update of the Johns Hopkins experience","volume":"29","author":"Tosoian","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.03.006_bib0006","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eururo.2009.10.025","article-title":"The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy","volume":"58","author":"Lee","year":"2010","journal-title":"Eur Urol"},{"issue":"28","key":"10.1016\/j.urolonc.2023.03.006_bib0007","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","article-title":"Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2023.03.006_bib0008","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ejca.2011.11.024","article-title":"Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy","volume":"48","author":"Sun","year":"2012","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2023.03.006_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bju.12115","article-title":"Conditional survival after nephrectomy for renal cell carcinoma (RCC): Changes in future survival probability over time","volume":"111","author":"Bianchi","year":"2013","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2023.03.006_bib0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.eururo.2014.08.003","article-title":"Conditional survival after radical nephroureterectomy for upper tract carcinoma","volume":"67","author":"Ploussard","year":"2015","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2023.03.006_bib0011","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jso.25877","article-title":"Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract","volume":"121","author":"Rosiello","year":"2020","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.03.006_bib0012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.6004\/jnccn.2019.7350","article-title":"Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy","volume":"18","author":"Palumbo","year":"2020","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.urolonc.2023.03.006_bib0013","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00345-019-02869-6","article-title":"Conditional survival of patients with stage I\u2013III squamous cell carcinoma of the penis: Temporal changes in cancer-specific mortality","volume":"38","author":"Mistretta","year":"2020","journal-title":"World J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2023.03.006_bib0014","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.22563","article-title":"Conditional survival in head and neck squamous cell carcinoma: Results from the SEER dataset 1973-1998","volume":"109","author":"Fuller","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2023.03.006_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2008.01.033","article-title":"Conditional survival in ovarian cancer: Results from the SEER dataset 1988-2001","volume":"109","author":"Choi","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"35","key":"10.1016\/j.urolonc.2023.03.006_bib0016","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1200\/JCO.2009.23.1860","article-title":"Practical application of a calculator for conditional survival in colon cancer","volume":"27","author":"Chang","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.03.006_bib0017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000488772","article-title":"Multiparametric magnetic-resonance to confirm eligibility to an active surveillance program for low-risk prostate cancer: Intermediate time results of a third referral high volume centre active surveillance protocol","volume":"101","author":"Luzzago","year":"2018","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.urolonc.2023.03.006_bib0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41391-019-0160-3","article-title":"Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up","volume":"23","author":"Luzzago","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.urolonc.2023.03.006_bib0019","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.03.006_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 Update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.03.006_bib0021","first-page":"16","article-title":"PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2","volume":"69","author":"Weinreb","year":"2019","journal-title":"HHS Public Access"},{"issue":"16","key":"10.1016\/j.urolonc.2023.03.006_bib0022","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1200\/JCO.2003.04.521","article-title":"Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark","volume":"21","author":"Skuladottir","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.03.006_bib0023","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.juro.2016.06.083","article-title":"Stricter active surveillance criteria for prostate cancer do not result in significantly better outcomes: A comparison of contemporary protocols","volume":"196","author":"Komisarenko","year":"2016","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.03.006_bib0024","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bju.13836","article-title":"Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer","volume":"120","author":"Alberts","year":"2017","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2023.03.006_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clgc.2017.10.020","article-title":"Baseline multiparametric MRI for selection of prostate cancer patients suitable for active surveillance: Which features matter?","volume":"16","author":"Sanguedolce","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2023.03.006_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bju.15623","article-title":"Repeat MRI during active surveillance: Natural history of prostatic lesions and upgrading rates","volume":"129","author":"Luzzago","year":"2022","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2023.03.006_bib0027","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/JU.0000000000001903","article-title":"Factors associated with discontinuation of active surveillance among men with low-risk prostate cancer: A population-based study","volume":"206","author":"Timilshina","year":"2021","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.03.006_bib0028","doi-asserted-by":"crossref","first-page":"132","DOI":"10.21037\/tau.2017.12.29","article-title":"Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSAdensity, with different thresholds for significant disease","volume":"7","author":"Schoots","year":"2018","journal-title":"Transl Androl Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:26:33Z","timestamp":1761042393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1078143923000911"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.03.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}